The warning letter follows inspections by the FDA at Dexcom’s manufacturing facilities in San Diego and Mesa, Ariz., and ...

The investment of over $6 million will expand LGM Pharma’s Rosenberg, Texas manufacturing facility as part of its Phase I ...

Medical device maker Dexcom said it has received a warning letter from the U.S. Food and Drug Administration following ...

The deal provides Viking Therapeutics with a secured dedicated annual supply of both injectable and oral versions of its ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...

Less than a year after CordenPharma earmarked a major chunk of change to beef up in peptide manufacturing for GLP-1s and ...

Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...

Shortly after making an M&A play to break into the CDMO business, Granules’ manufacturing bona fides have come under fire in ...

Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Eli Lilly said it plans to build three new plants in the United States to make the key ingredients used in pharmaceuticals, ...

The company is doubling plans for capital spending on U.S. factories as President Donald Trump pressures the pharma industry ...

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...